Geopolitics Alpha

Live · last trade · ETF proxies, Alpaca IEX

Natera’s Foresight Diagnostics Acquisition Named Deal of the Year by CBSA

Published . Updated .

Key takeaways

  • This report does not map to a usual set of affected companies.
  • Exposed: NTRA, DGX, XLV, LH, GH
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHANatera’s Foresight DiagnosticsAcquisition Named Deal of the Yearby CBSANTRAGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • NTRA Natera-20.9% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Natera belongs to, so it often moves with news about it.

  • LH Labcorp Holdings+20.7% 30d

    Labcorp Holdings is a peer of Natera in medical laboratories; rivals often move on the same news.

  • DGX Quest Diagnostics+11.3% 30d

    Quest Diagnostics is a peer of Natera in medical laboratories; rivals often move on the same news.

  • GH Guardant Health-9.2% 13d

    Guardant Health is a peer of Natera in medical laboratories; rivals often move on the same news.

  • CAI Caris Life Sciences-15.5% 30d

    Caris Life Sciences is a peer of Natera in medical laboratories; rivals often move on the same news.

  • GRAL Grail-11.6% 12d

    Grail is a peer of Natera in medical laboratories; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
NTRAPrices arriving within minutes———after closeafter closeafter closeafter close
XLVPrices arriving within minutes———after closeafter closeafter closeafter close
LHPrices arriving within minutes———after closeafter closeafter closeafter close
DGXPrices arriving within minutes———after closeafter closeafter closeafter close
GHPrices arriving within minutes———after closeafter closeafter closeafter close
CAIPrices arriving within minutes———after closeafter closeafter closeafter close
GRALPrices arriving within minutes———after closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Natera’s Foresight Diagnostics Acquisition Named Deal of the Year by CBSA Oncodaily

Source: Oncodaily

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Natera’s Foresight Diagnostics Acquisition Named Deal of the Year by CBSA” scores 12 out of 100. The score uses 1 source.